Arabic Arabic English English French French German German

FDA Approves New HIV Treatment for Patients With Limited Treatment Options

FDA approved Rukobia (fostemsavir), a new antiretroviral medication for adult patients with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.
Disclaimer: This story is auto-aggregated by a computer program and has not been created or edited by HFACULTY News. Publisher: FDA Press Releases RSS Feed Click this link to read the full content from the Publisher Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Coronavirus (COVID-19) Update: FDA Authorizes Additional COVID-19 Combination Diagnostic Test Ahead of Flu Season

Next Post

Coronavirus (COVID-19) Update: Daily Roundup July 2, 2020

Related Posts